Ivacaftor hydrate 5109 HCl Sodium carbenicillin

Sodium carbenicillin

and as an anticonvulsant

InChi: InChI=1S/C29H34Cl2FN3O3/c1-28(2

4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3

Ivacaftor hydrate 5109 HCl Sodium carbenicillinVX 770, is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, who account for 45% cases of cystic fibrosis, and is included in a combination drug, lumacaftor ivacaftor, which is used to treat people with cystic fibrosis who have the F508del mutation in CFTR. Ivacaftor is a "potentiator" of CFTR, meaning it increases the probability that the defective channel